Navigation Links
Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals
Date:10/20/2009

NANJING, China, Oct. 20 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading pharmaceutical company specializing in development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced an agreement with OSI Pharmaceuticals, Inc., to develop, manufacture, and market its KDR/Kit inhibitor OSI-930 in China.

Headquartered in Long Island, OSI is a NASDAQ listed pharmaceutical company specialized in discovery and development of innovative molecular targeted therapies. OSI-930 is an orally active inhibitor of two clinically validated targets: c-Kit and the vascular endothelial growth factor receptor-2 (VEGFR-2). OSI-930 is designed to target both cancer cell proliferation and blood vessel growth (angiogenesis) in selected tumors. In preclinical studies, OSI-930 shows broad efficacy in tumor models representative of small cell lung cancer, glioblastoma, colorectal, renal, head and neck, non-small cell lung cancer and gastric cancers. The company completed a phase I dose escalation study of OSI-930 in healthy volunteers. A phase I single agent dose escalation study in cancer patients has identified a recommended phase II dose and a phase Ib dose escalation study with erlotinib has also identified a recommended dose for the combination. Both phase I studies in cancer patients have been reported at recent ASCO meetings.

"OSI-930 has potential to help cancer patients, and we are delighted to cooperate with OSI Pharmaceuticals to promote this treatment in China," commented Mr. Jinsheng Ren, Chairman and Chief Executive Officer of Simcere Pharmaceutical Group. "We believe that this is a groundbreaking agreement which will become a model for future R&D cooperation between Chinese and foreign pharmaceutical companies."

'/>"/>
SOURCE Simcere Pharmaceutical Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 6, 2015 Alexza Pharmaceuticals, Inc. (Nasdaq: ... ended March 31, 2015.  The net loss and the ... million and $13.0 million, respectively, compared to $10.7 million ... respectively.  At March 31, 2015, Alexza had consolidated cash, ... million. "We continue to focus on ways ...
(Date:5/6/2015)... Lannett Company, Inc. (NYSE: LCI ) today reported ... March 31, 2015.  For the fiscal ... million from $80.0 million in last year,s third quarter.  ... of net sales, from $56.1 million, or 70% of ... $9.2 million from $10.6 million for the fiscal 2014 ...
(Date:5/6/2015)... /CNW/ - Celebrities, bloggers and influencers across North America ... important message that melanoma prevention begins with parents-encouraging everyone to ... Hilary Duff , and parenting author Alyson Schafer ... networks on Monday to share this poignant video message: ... David Cornfield Melanoma Fund (DCMF)-producers of the viral ...
Breaking Medicine Technology:Alexza Reports 2015 First Quarter Financial Results 2Alexza Reports 2015 First Quarter Financial Results 3Alexza Reports 2015 First Quarter Financial Results 4Alexza Reports 2015 First Quarter Financial Results 5Alexza Reports 2015 First Quarter Financial Results 6Alexza Reports 2015 First Quarter Financial Results 7Alexza Reports 2015 First Quarter Financial Results 8Alexza Reports 2015 First Quarter Financial Results 9Alexza Reports 2015 First Quarter Financial Results 10Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 2Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 3Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 4Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 5Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 6Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 8Celebrities Tweet Their Support of Melanoma Awareness Month and #newfamilyrule 2
... 2011 BioParadox, Inc., a regenerative medicine company ... announced that Michael Kleine, President & Chief Executive ... Board of Directors. "Mr. Kleine,s impressive ... commercialization of our novel biologic cardiovascular therapies.  We ...
... Texas, Dec 12, 2011   e-MDs , the provider ... record (EHR), announced that providers at Southwest Family ... the first physicians in the state of Nebraska to ... funds from the Medicare EHR Incentive Program for their ...
Cached Medicine Technology:Regenerative Medicine Company BioParadox adds Healthcare and Medical Device Expert, Michael Kleine, to its Board of Directors 2e-MDs Physicians are Among Nebraska's First to Attest for Meaningful Use 2e-MDs Physicians are Among Nebraska's First to Attest for Meaningful Use 3
(Date:5/6/2015)... May 06, 2015 Corporate Executives ... of MEBC, an Alliance Award for excellence in ... FOCUS 2015, JDA’s annual user conference which brought ... and wholesale distribution sectors. This award recognizes MEBC, ... receiving services that advance their supply chain performance ...
(Date:5/6/2015)... May 06, 2015 The Beryl Institute ... of Patient Experience Journal (PXJ), an international, open ... around understanding and improving patient experience. The second volume ... experience conversation globally, helps align the voices engaged and ... , Published in association with The Beryl Institute, Volume ...
(Date:5/6/2015)... Marketing Maven announces a ... sanitation and hygiene nonprofit by GuideStar’s Philanthropedia. , “WaterAid ... and it brings our agency great joy to work ... “The ongoing relationship between WaterAid and Marketing ... learn about and support the nonprofit as they aim ...
(Date:5/6/2015)... 2015 Wolters Kluwer , a ... students, announced today that in a survey of nearly ... of the clinical decision support resource improves the quality ... 2014, UpToDate users in more than 170 countries worldwide ... on average. In Germany alone, 95% of all university ...
(Date:5/6/2015)... has opened press registration for TU-Automotive Detroit as the ... headlines of major publications world-wide. With 150+ speakers from ... to share their visions for the future of connected ... to go behind the scenes and hear major automakers’ ... year we’re releasing a preview of all the major ...
Breaking Medicine News(10 mins):Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:Press Registration for TU-Automotive Detroit Now Open 2
... free personal care for the elderly was planned as a ... dignity and security //for everyone in old age. But now ... funding. Many medical councils are alleging that they have already ... this week it was reported that more than 200 pensioners ...
... Berkeley National Library revealed that the DNA in the sperm of ... dwarfism begins to take its toll. The study was carried out ... period, .from 97 healthy men between the age of 22 and ... out the sperms for this study. , The ...
... researchers to find out about the breast cancer in younger ... ,Comparing with the white women the number of black ... contrary the mortality rate among the black women is much ... blacks under the age of 50 have a 77 percent ...
... A P J Abdul Kalam today dedicated to ... treating head and neck cancer. // ... monoclonal antibody, BioMab EGFR (epidermal growth factor receptor), ... cancer cell-specific antigens and inducing an immunological response ...
... The NHS computer link, which was to have cost ?6.2 ... billion projects//. Experts say this is a waste of the ... Oxford University Computing Laboratory, said, 'This programme shows many signs ... concerns about computer products being used in a way that ...
... order to safeguard the health of pregnant women canned tuna ... in it! ,The actions and steps are ... found as much mercury as white tuna., ,Highlighting ... mercury in the bloodstream may harm developing nervous systems., ...
Cached Medicine News:Health News:Breast Cancer Mortality Rate is Higher Among Black Women 2Health News:Breast Cancer Mortality Rate is Higher Among Black Women 3
Provides rigid support and immobilization for the knee...
The Bledsoe Ultimate CI is a sport functional knee brace designed for instabilities of combined ACL and PCL injured knees. Additional knee injuries to the medial collateral ligament along with the cr...
... The Bledsoe Revolution ... for speed fitting under ... frees the surgeon or ... time-consuming post-op fitting and ...
The Bledsoe Basic Knee Brace offers a broad range of features that are unmatched by any other brace in its price range. Application of this brace is the easiest of any brace on the market....
Medicine Products: